Angiotensin II antagonists in patients with recurrent hepatitis C virus infection after liver transplantation.
Cholongitas
Evangelos
E
Vibhakorn
Shusang
S
Lodato
Francesca
F
Burroughs
Andrew K
AK
D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D001706:Biopsy; D018450:Disease Progression; D005260:Female; D019698:Hepatitis C, Chronic / Q000150:complications / Q000188:drug therapy* / Q000601:surgery; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000209:etiology; D008103:Liver Cirrhosis / Q000188:drug therapy* / Q000209:etiology / Q000601:surgery; D016031:Liver Transplantation; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications; D012008:Recurrence
D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors